Brief: Selectimmune Pharma Q2 Pretax Loss Widens To SEK 3.1 Mln
26/02/2021 08:06
Feb 26 (Reuters) - Selectimmune Pharma AB SELECTb.TE :
* Q2 PRETAX LOSS SEK 3.1 MILLION VERSUS LOSS SEK 2.0 MILLION
YEAR
AGO
Source text for Eikon: ID:nWkr4FS43M
Further company coverage: SELECTb.TE
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Selectimmune Pharma AB
See all newsBrief: Selectimmune Pharma Says Co's CEO Ann Gidner Will Leave Selectimmune Pharma
Brief: Lonza Collaborates With Selectimmune Collaborates To Develop Immunotherapeutic Drug Candidate
Brief: Selectimmune Pharma Q2 Pretax Loss Widens To SEK 3.1 Mln
Brief: Selectimmune Pharma Q1 Pretax Loss Narrows To SEK 2.2 Million
Brief: Selectimmune Pharma Signs Deal On Phase II Study For Infection Treatment